Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Fentanyl · Fentanyl Citrate, Sublimaze Preservative Free

Small molecule · Agonist of mu-type opioid receptor (OPRM1) · developed by Rising

Approved FDA, Feb 1968
1 Registered trials

What is Fentanyl?

Fentanyl is an opioid agonist that acts on opioid receptors to produce analgesia and sedation. It is used in anesthesia, including analgesic supplementation, premedication, induction and maintenance, and in the immediate postoperative period.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Fentanyl Citrate, Sublimaze Preservative Free
Drug type
Small molecule
Targets
mu-type opioid receptor (OPRM1)
Mechanism
Agonist of mu-type opioid receptor (OPRM1)
Therapy area
Oncology
Developer
Rising
In trials of
INDV
FDA status
Approved as Fentanyl Citrate, Sublimaze Preservative Free (February 19, 1968), NDA016619 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Aug 24, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03747341 Phase 1 Healthy Completed INDV

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

HealthyOpioid Use

Other drugs acting on OPRM1

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.